Sandbox:Nasrin
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]
COVID-19 | |||||||||||||||||||||||||||||||||||||||||||||||
30-40% Asymptomatic | 60-70% Symptomatic | ||||||||||||||||||||||||||||||||||||||||||||||
Asymptomatic carrier | 80% Mild symtoms | 14% Severe symptoms | 6% Critically ill | ||||||||||||||||||||||||||||||||||||||||||||
Fever Chills Cough Headache Sore throat Nasal congestion or secretion Fatigue Body aches loss of taste or smell Nausea or vomiting Diarrhea | Severe Dyspnea Chest pain Severe weakness new Confusion Central Cyanosis | Death | |||||||||||||||||||||||||||||||||||||||||||||
CT manifestations of COVID-19 | |||
---|---|---|---|
CT findings | Definition | CT picture | |
Ground glass opacity |
|
||
Consolidation |
|
[[file | |
Crazy paving pattern |
|
| |
Reticuldar pattern |
|
[[file | |
Air bronchogram |
|
[[file | |
Bronchiectasis |
|
[[file |